Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Yueyao Du"'
Publikováno v:
Genes and Diseases, Vol 10, Iss 2, Pp 447-456 (2023)
Autophagy, as a special programmed cell death, is a critical degradative process that eliminates intracellular abnormal proteins or damage organelles to balance cell energy and favor cell metabolism with autophagy-related (ATG) proteins. Autophagy ac
Externí odkaz:
https://doaj.org/article/68702860c248460caac8423e6a849d57
Autor:
Huaying Xie, Tingting Yan, Xinxin Lu, Yueyao Du, Shuguang Xu, Yu Kong, Liangjie Yu, Jian Sun, Liheng Zhou, Jun Ma
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundTNBC, whose clinical prognosis is poorer than other subgroups of breast cancer, is a malignant tumor characterized by lack of estrogen receptors, progesterone hormone receptors, and HER2 overexpression. Due to the lack of specific targeted
Externí odkaz:
https://doaj.org/article/9cca67cd04c442239b904ba24966df72
Autor:
Xiaonan Sheng, Huijuan Dai, Yueyao Du, Jing Peng, Rui Sha, Fan Yang, Liheng Zhou, Yanping Lin, Shuguang Xu, Yifan Wu, Wenjin Yin, Jinsong Lu
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-17 (2021)
Abstract Background Triple negative breast cancer (TNBC) is a subtype of breast cancer with poor prognosis and lack of effective treatment target. Here we screened differentially expressed lncRNAs through bioinformatics analysis and identified CARMN
Externí odkaz:
https://doaj.org/article/d9dbaeb1b85242e785f0af2cb7b09ef6
Publikováno v:
Radiation Oncology, Vol 15, Iss 1, Pp 1-8 (2020)
Abstract Background Treatment for locally recurrent rectal cancer after surgery is still a challenge. With the physical and biological advantages, carbon-ion radiotherapy (CIRT) could be a choice for these patients. The purpose of this study was to i
Externí odkaz:
https://doaj.org/article/dfefef41201247a5a000e1a8a4dda54a
Publikováno v:
Journal of Immunology Research, Vol 2022 (2022)
Objective. To identify trastuzumab-resistant genes predicting drug response and poor prognosis in human epidermal growth factor receptor 2 positive (HER2+) breast cancer. Methods. Gene expression profiles from the GEO (Gene Expression Omnibus) databa
Externí odkaz:
https://doaj.org/article/bf62575e58fe4010956842558f655556
Autor:
Huijuan Dai, Xiaonan Sheng, Yaohui Wang, Liheng Zhou, Yanping Lin, Yueyao Du, Fan Yang, Rui Sha, Jing Peng, Linli Yao, Wenjin Yin, Jinsong Lu
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Hypoxia-induced chemotherapy resistance is the main hindrance for solid tumor treatment. Hypoxia inducible factor-1α (HIF1α), an adaptive gene of hypoxia condition, played an important role in affecting chemotherapy sensitivity for many cancer type
Externí odkaz:
https://doaj.org/article/5371e700d2af4117a4c56d0881ad2ebd
Autor:
Yan Liu, Jiaxin Sun, Tong Wu, Xiaoying Lu, Yueyao Du, Hongwei Duan, Weifeng Yu, Diansan Su, Jinsong Lu, Jie Tian
Publikováno v:
Cancer Medicine, Vol 8, Iss 18, Pp 7603-7612 (2019)
Abstract Adrenergic receptors (ARs) have gained attention for their involvement in breast cancer (BC) progression. Dexmedetomidine, a selective α2‐AR agonist, has been reported to increase the malignancy of BC cells in vitro or stimulate tumor gro
Externí odkaz:
https://doaj.org/article/6427649249f24a9c8471d0df319e83ca
Autor:
Shan Zhang, Yaohui Wang, Yan Wang, Jing Peng, Chenwei Yuan, Liheng Zhou, Shuguang Xu, Yanping Lin, Yueyao Du, Fan Yang, Jie Zhang, Huijuan Dai, Wenjin Yin, Jinsong Lu
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Background: We aimed to explore whether the expression of serum miR-222-3p might contribute to early prediction of therapeutic response, clinical outcomes, and adverse events for HER2-positive breast cancer patients receiving neoadjuvant therapy (NAT
Externí odkaz:
https://doaj.org/article/4200cd22ee93419db166bcc4a19ba597
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e83646 (2014)
BACKGROUND: Although the prognosis of patients with small (≤1cm) tumors is generally favorable, emerging data suggests that biological behavior varies between intrinsic subtypes in such patients. Furthermore, it still remains unclear whether HER2-p
Externí odkaz:
https://doaj.org/article/0778240417334ee59ca2a750920f5659
Autor:
Yiwei Jiang, Wenjin Yin, Liheng Zhou, Tingting Yan, Qiong Zhou, Yueyao Du, Zhenzhou Shen, Zhimin Shao, Jinsong Lu
Publikováno v:
PLoS ONE, Vol 7, Iss 3, p e32474 (2012)
BACKGROUND: Capecitabine is effective and indicated for the salvage treatment of metastatic breast cancer. Therefore, it is essential to evaluate the efficacy of capecitabine in the adjuvant setting. There have been two large randomized studies to de
Externí odkaz:
https://doaj.org/article/900d418d3402449e915d7456157b4f9b